{"title":"严重哮喘患者与抗白细胞介素-5疗法相关的关节表现：病例系列。","authors":"Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, Gilles Devouassoux, Marine Merveilleau, Maud Russier, Gisèle Mourin, Johana Pradelli, Philippe Bonniaud, Mathilde Le Brun, Esther Ebstein, Pierre-Antoine Juge, Agnès Lillo-Lelouet, Camille Taillé","doi":"10.1183/23120541.00935-2023","DOIUrl":null,"url":null,"abstract":"<p><p><b>Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment.</b> https://bit.ly/3vfPn4k.</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"10 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895420/pdf/","citationCount":"0","resultStr":"{\"title\":\"Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.\",\"authors\":\"Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, Gilles Devouassoux, Marine Merveilleau, Maud Russier, Gisèle Mourin, Johana Pradelli, Philippe Bonniaud, Mathilde Le Brun, Esther Ebstein, Pierre-Antoine Juge, Agnès Lillo-Lelouet, Camille Taillé\",\"doi\":\"10.1183/23120541.00935-2023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment.</b> https://bit.ly/3vfPn4k.</p>\",\"PeriodicalId\":11739,\"journal\":{\"name\":\"ERJ Open Research\",\"volume\":\"10 1\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895420/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ERJ Open Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/23120541.00935-2023\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00935-2023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.
Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment. https://bit.ly/3vfPn4k.
期刊介绍：
ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
